Bare metal stent versus paclitaxel eluting stent for intermediate length femoropopliteal arterial lesions (BATTLE trial): study protocol for a randomized controlled trial

BACKGROUND: Currently, endovascular treatment is indicated to treat femoropopliteal lesions ≤15 cm. However, the Achilles’ heel of femoropopliteal endovascular repair remains restenosis. Paclitaxel eluting stents have shown promising results to prevent restenosis in femoropopliteal lesions compared...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Trials
Glavni autori: Gouëffic, Yann, Kaladji, Adrien, Guyomarch, Béatrice, Montagne, Carine, Fairier, Damien, Gestin, Simon, Riche, Valéry-Pierre, Vent, Pierre Alexandre, Chaillou, Philippe, Costargent, Alain, Patra, Philippe
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2014
Teme:
Study Protocol
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4226912/
https://ncbi.nlm.nih.gov/pubmed/25359394
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1745-6215-15-423
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items